The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESMO 2019 | Managing T-cell lymphomas in light of the updated WHO classification
In light of the updated WHO classification, Francesco d’Amore, MD, Aarhus University, Aarhus, Denmark, talks about the management of T-cell lymphomas including T-follicular helper cell (TFH), monomorphic epithelial intestinal T-cell lymphoma (MEITL), and anaplastic large-cell lymphoma (ALCL). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
